As an IT startup, we operate in a fast-paced, rapidly changing world. Here, we'll share news and updates as Q1.6 continues to evolve.
It's important to our team to share as much as possible to help you decide what's best for your patients. If you have any questions about our articles, please get in touch.
"Q1.6 revolutionizes the way we gather evidence data for real-world evidence (RWE) studies, providing a lean and efficient solution."
Product Manager, Large Pharma Company
"Implementing Q1.6 has allowed us to increase the average number of patients we can accommodate per square meter."
Head Surgeon, Radboud UMC
"With Q1.6, we have successfully reduced our patient dropout rate from 40% to 29%, improving the continuity of care and patient outcomes."
Board Member, Large International Pharma Company
"Thanks to the Q app's early notifications, we can now prompt patients to visit their doctors within the crucial first few days of a crisis. This has significantly reduced hospitalizations and shortened hospital stays compared to the past."
COPD Product Manager, Insurance Company
"As an orthopedic specialist focusing on shoulder injuries, I now have access to an unprecedented amount of data through Q1.6."
Orthopedic Surgeon (Shoulder Specialist)
"Q1.6 has proven to be a reliable and effective solution in our medical practice, delivering seamless performance." “It just works.”
Doctor, Radboud UMC
"Yesterday, we received a critical Q1.6 notification for a patient who initially declined to come for follow-up. Unfortunately, we later discovered that the patient indeed required emergency care. This incident highlights the importance of timely communication facilitated by Q1.6."
Healthcare Professional, Dutch Hospital
EPRO CONSULTANCY AND SOFTWARE LICENCES: ONE OF THEM NEEDS TO BE REDUCED
Q1.6 is convinced that the worlds of ePro and sensor technology are merging. In parallel, further automation in clinical trial deployment is crucial to reducing costs.
Q1.6 is testing the next version of its Rule Based Engine to combine these two worlds, combining a self-service track with automated data transfer (raw and aggregated) into the CDMS systems used in trials.
Version 3.5 is planned for release in summer 2021.
Q1.6 TAKES 2ND PLACE IN MEDTRONIC'S WE STAND CLOSE 2020
Dr Patrick Vriens, vascular surgeon at ETZ Tilburg, was awarded 2nd place in a recent Medtronic contest for his research in collaboration with Q1.6. Congratulations to Patrick and his team, which received Medtronic funding to continue its work!
We'll keep you updated on the outcome of the study.
ISO CERTIFICATE AND QMS
Following 5 consecutive annual audits, Q1.6 has been granted the ISO27001 certificate. Our Quality Management System (QMS) conforms to ISO13485.
QR CODE ON STUDY SAMPLES
Teams needed to be certain that their samples collected via the patients were send back on time.
Normally it was an extensive effort to contact patients, remind them to send their sample, and then hope it would arrive on time.
By including the QR code in the Q1.6 platform to remind the patients to act, the study team was able to get a 95% return rate in time.
(short demo video here)
EQ-5D-5L AND GAD-7
These 2 are our latest validated questionnaires available to use in your study